V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270018540 | 270010734 | 1.72 | 77.5 | Curative (C) | 2016-12-19 | 2018-01-25 | Cetuximab + FLUOROURACIL | N | null | 270025878 | FLUOROURACIL + RT |
| 270018541 | 270010738 | null | 63 | Palliative (P) | null | 2017-07-22 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 2 | N | 270000003 | ICE |
| 270018542 | 270010741 | 1.83 | null | Palliative (P) | 2017-06-27 | 2017-07-27 | DA 3 + 10 | N | N | 270000307 | DOCETAXEL |
| 270018543 | 270010748 | null | 128 | Curative (C) | 2018-05-27 | 2018-06-02 | Carboplatin + Pemetrexed | N | N | 270001351 | FLUOROURACIL + RT |
| 270018544 | 270019727 | 0 | 76.4 | Palliative (P) | 2018-11-21 | 2018-11-25 | CARBOPLATIN + PACLITAXEL | N | N | 270002435 | DOCETAXEL |
| 270018545 | 270010762 | null | 88.6 | Curative (C) | 2017-06-10 | 2017-06-10 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 270003718 | RUXOLITINIB |
| 270018546 | 270010766 | 1.62 | 92 | Palliative (P) | 2018-01-12 | 2018-01-26 | Carboplatin + Etoposide iv&po | N | N | 270004101 | GEMCARBO |
| 270018547 | 270015020 | 1.91 | null | null | 2017-09-07 | 2017-09-12 | OXALIPLATIN + MDG + PANITUMUMAB | 2 | N | 270004490 | OXALIPLATIN |
| 270018548 | 270010772 | 1.68 | 109.5 | Curative (C) | 2018-01-01 | 2018-01-04 | CARBOPLATIN + RT | 02 | N | 270004767 | IBRUTINIB |
| 270018549 | 270010774 | 1.78 | 63.8 | Palliative (P) | 2018-11-20 | 2018-11-20 | BEAM + FLUDARABINE | N | N | 270004836 | CARBOPLATIN + RT |
| 270018550 | 270010777 | null | 99.2 | Palliative (P) | 2019-04-10 | 2019-08-07 | Carboplatin + Etoposide iv&po | null | N | 270004923 | FLUOROURACIL + RT |
| 270018551 | 270015025 | 1.68 | 59.8 | Palliative (P) | 2017-02-23 | 2017-08-13 | CAPECITABINE + CETUXIMAB + CISPLATIN | N | Y | 270004960 | CARBO + FLUOROURACIL |
| 270018552 | 270017292 | null | null | Palliative (P) | 2019-05-16 | 2019-05-19 | R-GEM-P | 99 | null | 270005171 | BREVITY TRIAL |
| 270018553 | 270010787 | null | null | Curative (C) | 2018-01-29 | 2018-01-29 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | null | 270006274 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270018554 | 270010791 | 1.81 | 86.8 | Neo-adjuvant (N) | 2016-06-11 | 2016-06-30 | CAPECITABINE + CETUXIMAB + IRINOTECAN | N | null | 270006324 | CARBOPLATIN + CETUXIMAB + FU |
| 270018555 | 270010796 | 1.73 | 87.1 | Curative (C) | 2014-08-24 | 2014-09-06 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | N | N | 270007266 | HYDROXYCARBAMIDE |
| 270018556 | 270015036 | 1.72 | null | null | 2018-12-13 | 2018-12-14 | CARBOPLATIN + RT | 99 | Y | 270008125 | CISPLATIN + PEMETREXED |
| 270018557 | 270015037 | 1.76 | 81.35 | Curative (C) | 2016-09-12 | 2017-10-10 | DA | 02 | N | 270010216 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 270018558 | 270010808 | null | 101.4 | Curative (C) | 2016-04-10 | 2016-04-11 | DA 3 + 10 | N | N | 270010445 | FLUOROURACIL + RT |
| 270018559 | 270010810 | 1.84 | 78.6 | Curative (C) | 2018-03-16 | 2018-03-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 270010649 | FLUOROURACIL + MITOMYCIN + RT |
| 270018560 | 270019732 | 1.86 | 88 | Disease modification (D) | 2018-04-16 | 2018-04-17 | CARBOPLATIN + GEMCITABINE | 02 | null | 270011974 | CARBOPLATIN + CETUXIMAB + FU |
| 270018561 | 270010816 | 1.69 | 86 | Not known (9) | 2018-10-23 | 2018-11-08 | CVP | N | N | 270012127 | BENDAMUSTINE + RITUXIMAB |
| 270018562 | 270010818 | 1.75 | 104.2 | Palliative (P) | 2017-01-01 | 2017-04-22 | OXALIPLATIN + MDG + PANITUMUMAB | N | N | 270013426 | CETUXIMAB + IRINOTECAN |
| 270018563 | 270017303 | 0 | 40 | Palliative (P) | 2017-10-15 | 2018-01-08 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 270013472 | MITOMYCIN |
| 270018564 | 270019316 | 1.66 | 63 | Disease modification (D) | 2019-03-24 | 2019-05-06 | Cisplatin + Pemetrexed | 02 | N | 270013472 | CYTARABINE |
| 270018565 | 270019316 | 1.79 | null | Curative (C) | 2018-09-14 | 2018-09-19 | Carboplatin + Etoposide IV 3 day | N | null | 270013472 | CETUXIMAB + CISPLATIN + FU |
| 270018566 | 270010826 | null | 78.7 | Curative (C) | 2018-04-21 | 2018-07-07 | ICE | N | N | 270014838 | EVEROLIMUS |
| 270018567 | 270010829 | null | 77.5 | Curative (C) | 2018-01-26 | 2018-02-17 | Carbo F | N | N | 270015249 | CARBOPLATIN + RT |
| 270018568 | 270010836 | 1.65 | null | Curative (C) | 2017-04-26 | 2017-05-16 | FLUOROURACIL + RT | N | null | 270016014 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270018569 | 270010838 | 1.64 | 67.8 | Curative (C) | 2019-10-02 | 2019-10-08 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 270017533 | CARBOPLATIN + RT |
| 270018570 | 270015053 | 1.72 | null | Curative (C) | 2018-09-20 | 2018-12-21 | FLUOROURACIL + RT | 02 | N | 270018514 | CARBOPLATIN + RT |
| 270018571 | 270010847 | 1.76 | 51.9 | Palliative (P) | 2015-07-11 | 2015-08-16 | Carboplatin + Etoposide IV 3 day | N | N | 270019701 | CARBOPLATIN + IRINOTECAN |
| 270018572 | 270010852 | null | 59.7 | Adjuvant (A) | 2018-11-09 | 2019-01-28 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 270019766 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 270018573 | 270010858 | 1.76 | 58.8 | Palliative (P) | 2018-04-24 | 2018-04-25 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | null | 270020199 | IBRUTINIB |
| 270018574 | 270010860 | 0 | 93 | Curative (C) | 2015-03-30 | 2015-03-30 | Abiraterone | Y | N | 270020318 | CARBOPLATIN + RT |
| 270018575 | 270010861 | null | null | null | 2014-01-03 | 2014-01-27 | Trifluridine + Tipiracil + Trifluridine and Tipiracil | N | N | 270020349 | RALTITREXED |
| 270018576 | 270015063 | null | 85 | Palliative (P) | 2018-02-23 | 2018-02-23 | Irinotecan + Raltitrexed | N | N | 270020461 | CARBOPLATIN + CETUXIMAB + FU |
| 270018577 | 270020166 | 1.94 | 67.4 | Curative (C) | 2019-04-27 | 2019-05-22 | Bortezomib + MELPHALAN | 2 | N | 270020876 | BEVACIZUMAB + CAPECITABINE |
| 270018578 | 270010866 | 1.87 | 65.2 | Palliative (P) | 2018-04-07 | 2018-04-10 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | N | N | 270021311 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 270018579 | 270010871 | null | null | Palliative (P) | null | 2019-01-20 | IRINOTECAN + MDG + PANITUMUMAB | null | N | 270021755 | CISPLATIN + ETOPOSIDE + RT |
| 270018580 | 270017315 | null | 103 | Palliative (P) | 2018-04-20 | 2018-04-25 | Raltitrexed | 02 | N | 270021908 | FEC |
| 270018581 | 270017316 | 1.94 | 139.2 | Palliative (P) | 2016-06-23 | 2016-07-01 | Docetaxel | N | N | 270022303 | CARBOPLATIN + CETUXIMAB + FU |
| 270018582 | 270010886 | 1.74 | 74.6 | Palliative (P) | 2016-12-07 | 2016-12-10 | Cyclophosphamide PO +Vinorelbine IV | N | N | 270022394 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 270018583 | 270010890 | null | null | Palliative (P) | 2015-10-11 | 2016-02-28 | CAPECITABINE + CETUXIMAB | N | N | 270022687 | PACLITAXEL |
| 270018584 | 270019323 | null | 68.4 | Palliative (P) | 2017-09-07 | 2017-10-23 | R GDP | null | N | 270022690 | DOXORUBICIN |
| 270018585 | 270015075 | null | 69.3 | Disease modification (D) | 2016-10-13 | 2016-10-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 270023466 | CAPECITABINE + CETUXIMAB |
| 270018586 | 270010899 | 1.7 | null | Palliative (P) | 2017-04-08 | 2017-11-08 | Bevacizumab + Capecitabine | N | null | 270023795 | CARBOPLATIN + RT |
| 270018587 | 270010906 | 1.77 | 92.2 | Disease modification (D) | 2016-09-11 | 2017-02-05 | FLUOROURACIL + MITOMYCIN + RT | N | N | 270023952 | BEVACIZUMAB + CAPE + IRINOTECAN |
| 270018588 | 270010912 | 1.78 | 59.6 | Palliative (P) | 2016-07-20 | 2016-07-27 | Carboplatin + Cetux + FU (>Cycle 2) | 2 | N | 270024404 | BLEOMYCIN |
| 270018589 | 270017323 | 1.7 | 63 | Palliative (P) | 2017-08-21 | 2017-09-04 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 270024838 | FEC |